Pages that link to "Q34785845"
Jump to navigation
Jump to search
The following pages link to Phase I clinical trial of i.v. ascorbic acid in advanced malignancy (Q34785845):
Displaying 50 items.
- Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects (Q21136326) (← links)
- Antiproliferative effect of ascorbic acid is associated with the inhibition of genes necessary to cell cycle progression (Q21143876) (← links)
- Treatment of Pancreatic Cancer with Pharmacological Ascorbate (Q26800853) (← links)
- Ascorbate as a co-factor for fe- and 2-oxoglutarate dependent dioxygenases: physiological activity in tumor growth and progression (Q26822640) (← links)
- Increasing Superoxide Production and the Labile Iron Pool in Tumor Cells may Sensitize Them to Extracellular Ascorbate (Q27021794) (← links)
- Commonly used methods of complementary medicine in the treatment of breast cancer (Q27691359) (← links)
- SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways (Q28385000) (← links)
- Nutritional countermeasures targeting reactive oxygen species in cancer: from mechanisms to biomarkers and clinical evidence (Q28393187) (← links)
- High-dose intravenous vitamin C combined with cytotoxic chemotherapy in patients with advanced cancer: a phase I-II clinical trial (Q28545827) (← links)
- Mechanisms of ascorbate-induced cytotoxicity in pancreatic cancer (Q30492805) (← links)
- Synergistic potentiation of D-fraction with vitamin C as possible alternative approach for cancer therapy (Q33734981) (← links)
- Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer (Q34137350) (← links)
- The effect of intravenous vitamin C on cancer- and chemotherapy-related fatigue and quality of life (Q34349450) (← links)
- Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy (Q34359754) (← links)
- Vitamin C acts indirectly to modulate isotype switching in mouse B cells (Q34389387) (← links)
- Review of high-dose intravenous vitamin C as an anticancer agent (Q34406887) (← links)
- Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review (Q34458788) (← links)
- Vitamin C and cancer revisited (Q34595214) (← links)
- Oxalic acid excretion after intravenous ascorbic acid administration (Q34603325) (← links)
- Ascorbic acid inhibits antitumor activity of bortezomib in vivo (Q34606574) (← links)
- High concentrations of L-ascorbic acid specifically inhibit the growth of human leukemic cells via downregulation of HIF-1α transcription. (Q34693392) (← links)
- Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries (Q34729895) (← links)
- Treatment of irradiated mice with high-dose ascorbic acid reduced lethality (Q35049445) (← links)
- Comment on "Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer," i.e., all we are saying is, give C a chance (Q35082887) (← links)
- Intravenous Vitamin C and Cancer: A Systematic Review (Q35175163) (← links)
- Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer (Q35639007) (← links)
- High-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse (Q35917505) (← links)
- High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma (Q35971207) (← links)
- A reactive oxygen species activation mechanism contributes to JS-K-induced apoptosis in human bladder cancer cells (Q36149908) (← links)
- Mitochondrial Superoxide Dismutase Has a Protumorigenic Role in Ovarian Clear Cell Carcinoma (Q36296656) (← links)
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer (Q36351453) (← links)
- Production of ascorbic acid releasing biomaterials for pelvic floor repair. (Q36371230) (← links)
- Intravenous vitamin C in the treatment of shingles: results of a multicenter prospective cohort study (Q36577734) (← links)
- Modulation of Cytokines in Cancer Patients by Intravenous Ascorbate Therapy (Q36588833) (← links)
- Direct spectrophotometric measurement of supra-physiological levels of ascorbate in plasma. (Q36647008) (← links)
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. (Q36653078) (← links)
- Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH. (Q36653423) (← links)
- Ascorbic acid: chemistry, biology and the treatment of cancer. (Q36717267) (← links)
- Phase I clinical trial to evaluate the safety, tolerability, and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer (Q36952096) (← links)
- Potassium increases the antitumor effects of ascorbic acid in breast cancer cell lines in vitro. (Q36954195) (← links)
- Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation (Q37100095) (← links)
- Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients (Q37116018) (← links)
- Vitamin C increases viral mimicry induced by 5-aza-2'-deoxycytidine (Q37264298) (← links)
- Mechanism of action of vitamin C in sepsis: ascorbate modulates redox signaling in endothelium (Q37399000) (← links)
- In vitro and in vivo assessment of high-dose vitamin C against murine tumors (Q37406472) (← links)
- Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics (Q37406743) (← links)
- Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. (Q37607700) (← links)
- Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells. (Q37620415) (← links)
- The ROS-induced cytotoxicity of ascorbate is attenuated by hypoxia and HIF-1alpha in the NCI60 cancer cell lines. (Q37638916) (← links)
- Vitamins and prostate cancer risk (Q37718579) (← links)